We have observed
5 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after December 08, 2014).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
NOVEL TREATMENT METHOD
MODULATORS OF KV3 CHANNELS TO TREAT PAIN
HYDANTOIN MODULATORS OF KV3 CHANNELS
AROMATIC HETEROCYCLIC COMPOUNDS AS ANTIINFLAMMATORY COMPOUNDS
ANDROGRAPHOLIDE TREATS PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS